Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06802263 · ClinicalTrials.gov registry record · NA
MIRA CONNECT Study
A NA study of Pregnancy of Unknown Location (PUL), sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- NA
- Development phase
- 35
- Enrollment target
- 1
- Study location
NCT06802263 is a NA study of Pregnancy of Unknown Location (PUL) that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 35 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06802263, a NA study of Pregnancy of Unknown Location (PUL), is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this pilot study is to assess the accuracy and precision of an at-home quantitative urine beta hCG (b-hCG) test in the management of pregnancy of unknown location (PUL).
Conditions Studied
Interventions
- DIAGNOSTIC_TEST at-home quantitative urine b-hCG test
Study Locations (1)
Colorado
- University of Colorado - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2024-06-01 |
| Est. Completion | 2027-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06802263
The ClinicalTrials.gov registry entry for NCT06802263 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pregnancy of Unknown Location (PUL) appearing as the primary indexed condition, and to 1 intervention - of which at-home quantitative urine b-hCG test is the first listed.
NCT06802263 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT06802263 about?
NCT06802263 is a clinical study titled "MIRA CONNECT Study". The goal of this pilot study is to assess the accuracy and precision of an at-home quantitative urine beta hCG (b-hCG) test in the management of pregnancy of unknown location (PUL).
What is the current status of trial NCT06802263?
This trial is currently recruiting. It is a NA study. The enrollment target is 35 participants. The study started on 2024-06-01. Estimated completion is 2027-09-30.
What conditions does trial NCT06802263 study?
This clinical trial studies the following conditions: Pregnancy of Unknown Location (PUL).
What interventions are being tested in trial NCT06802263?
The interventions under investigation include: at-home quantitative urine b-hCG test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06802263?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06802263 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.